Mammoth Biosciences
Mammoth Biosciences is engaged in developing products based on CRISPR technology. Among possible applications are diagnostics, genome editing, and protein finding.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
- Combo news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Mammoth Biosciences
Mammoth Biosciences • 8 May 2023Mammoth Biosciences to Present at the 2023 Annual Meeting of the ...
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as ...
https://finance.yahoo.com/news/mammoth-biosciences-present-2023-annual-130000651.htmlMammoth Biosciences • 19 Apr 2023Curing disease with CRISPR with Trevor Martin from Mammoth ...
This week Darrell and Becca are joined by Trevor Martin the co-founder and CEO of Mammoth Biosciences, a startup that uses CRISPR to diagnose and find ...
https://techcrunch.com/2023/04/18/curing-disease-with-crispr-with-trevor-martin-from-mammoth-biosciences/Mammoth Biosciences • 5 Jan 2023Mammoth Biosciences to Present at 41st Annual J.P. Morgan ...
Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference ...
https://finance.yahoo.com/news/mammoth-biosciences-present-41st-annual-140000735.html